A 66-Year-Old-Man with Metastatic Prostate Cancer - Episode 4
Unmet Needs and Investigational Therapies in mCSPC
Dr Jason Hafron concludes his discussion of mCSPC by highlighting the need to work towards a cure for the disease, and two major clinical trials investigating triplet treatment regimens.
